DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Garon EB, Gandhi L, Rizvi N et al.
Antitumor activity of pembrolizumab (Pembro; MK-3475) and correlation with programmed death ligand 1 (PD-L1) expression in a pooled analysis of patients (pts) with advanced non-small cell lung carcinoma (NSCLC).
Ann Oncol 2014;
25 LBA 43
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.